Literature DB >> 31986228

Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.

Joseph V Pergolizzi1,2, Robert B Raffa2,3,4, Melanie H Rosenblatt5.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Opioid use in the United States has reached unprecedented-some would even say crisis-levels. Although many individuals use opioid drugs as part of legitimate pain management plans, a significant number misuse prescription or illicit opioids. With regular opioid use, individuals develop tolerance and physical dependence; both are predictable, physiologic responses to repeated opioid exposure. However, a substantial number of individuals who misuse opioids will develop opioid use disorder (OUD), a complex, primary, chronic, neurobiological disease rooted in genetic, environmental and psychosocial factors. This article discusses OUD, opioid receptor physiology, and opioid withdrawal symptomatology and pathophysiology, as well as current treatment options available to reduce opioid withdrawal symptoms in individuals with physical dependence and/or OUD.
METHODS: The research articles regarding OUD and its management have been reviewed thoroughly based on a PubMed literature search using keywords related to opioid dependence, its pathophysiology and current treatment strategies. RESULTS AND DISCUSSION: Tolerance/physical dependence and the behavioural characteristics associated with OUD reflect complex neurobiologic adaptations in several major systems of the brain, including the locus ceruleus and mesolimbic systems. Physical dependence is responsible for the distressing withdrawal symptoms individuals experience upon abrupt cessation or rapid dose reduction of exogenous opioids. Opioid withdrawal symptoms are a key driver behind continued opioid use, and a barrier to opioid discontinuation. Several opioid-based medications are available to treat patients with OUD; these treatments can diminish opioid withdrawal symptoms and cravings as well as block opioid effects in the event of relapse. Additionally, non-opioid drugs may be used during acute detoxification to help alleviate opioid withdrawal symptoms. WHAT IS NEW AND
CONCLUSION: The opioid crisis has produced many challenges for physicians, one being the need to determine which patients would benefit most from maintenance therapy and which may be candidates for opioid discontinuation. In addition to summarizing current understanding of OUD, we provide a new algorithm for determining the need for continued opioid use as well as examples of situations where management of opioid withdrawal symptoms is indicated.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  dependence; detoxification; opioid use disorder; opioid withdrawal symptoms; pain management

Year:  2020        PMID: 31986228     DOI: 10.1111/jcpt.13114

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  16 in total

1.  OpiTrack: A Wearable-based Clinical Opioid Use Tracker with Temporal Convolutional Attention Networks.

Authors:  Bhanu Teja Gullapalli; Stephanie Carreiro; Brittany P Chapman; Deepak Ganesan; Jan Sjoquist; Tauhidur Rahman
Journal:  Proc ACM Interact Mob Wearable Ubiquitous Technol       Date:  2021-09-14

2.  Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.

Authors:  Josue Jaramillo-Polanco; Cintya Lopez-Lopez; Yang Yu; Emma Neary; Alan Hegron; Meritxell Canals; Nigel W Bunnett; David E Reed; Alan E Lomax; Stephen J Vanner
Journal:  J Neurosci       Date:  2022-03-07       Impact factor: 6.709

Review 3.  Translational value of non-human primates in opioid research.

Authors:  Huiping Ding; Mei-Chuan Ko
Journal:  Exp Neurol       Date:  2021-01-14       Impact factor: 5.330

Review 4.  Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.

Authors:  George F Koob
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine.

Authors:  Soyon Ahn; Maya O Nesbit; Haiyan Zou; Giada Vacca; Peter Axerio-Cilies; Tran Van Sung; Anthony G Phillips
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

6.  Concordance between high antibiotic prescribing and high opioid prescribing among primary care physicians: a cross-sectional study.

Authors:  Bradley J Langford; Cynthia Chen; Nick Daneman; Kevin A Brown; Tara Gomes; Jennie Johnstone; Julie Wu; Valerie Leung; Gary Garber; Kevin L Schwartz
Journal:  CMAJ Open       Date:  2021-03-08

Review 7.  Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction.

Authors:  Caroline B Pantazis; Luis A Gonzalez; Brendan J Tunstall; Stephanie A Carmack; George F Koob; Leandro F Vendruscolo
Journal:  Sci Adv       Date:  2021-04-07       Impact factor: 14.136

8.  Evaluation of an emergency department-based opioid overdose survivor intervention: Difference-in-difference analysis of electronic health record data to assess key outcomes.

Authors:  Dennis P Watson; Tess Weathers; Alan McGuire; Alex Cohen; Philip Huynh; Clay Bowes; Daniel O'Donnell; Krista Brucker; Sumedha Gupta
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

9.  Morphine restores and naloxone-precipitated withdrawal depresses wheel running in rats with hindpaw inflammation.

Authors:  Michael M Morgan; Kristin Ataras
Journal:  Pharmacol Biochem Behav       Date:  2021-08-04       Impact factor: 3.697

Review 10.  A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.

Authors:  Ivan Urits; Anjana Patel; Robbie Zusman; Celina Guadalupe Virgen; Mohammad Mousa; Amnon A Berger; Hisham Kassem; Jai Won Jung; Jamal Hasoon; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.